ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1046

High-Grade Urothelial Carcinoma After BK Virus Nephropathy in an En Bloc Kidney Allograft from a Pediatric Donor

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Jabbar, Danish, Royal Free London NHS Foundation Trust, London, England, United Kingdom
  • Elshayeb, Mohamed Mohsen, Royal Free London NHS Foundation Trust, London, England, United Kingdom
  • Dunn, James, Royal Free London NHS Foundation Trust, London, England, United Kingdom
  • Salama, Alan D., Royal Free London NHS Foundation Trust, London, England, United Kingdom
Introduction

We report a rare case of high-grade UC in a pediatric en-bloc allograft more than 10 years after transplant, following severe BK viremia and biopsy-proven BK virus nephropathy (BKVN).

Case Description

A 37-year-old woman with ESKD of unknown etiology received a deceased-donor pediatric en-bloc kidney transplant in 2014.She received induction immunosuppression with basiliximab/methylprednisolone. Early complications included urinary leak, E. coli bacteremia, and hydronephrosis requiring nephrostomy/stenting.
Later in 2014, concurrent BK and CMV viremia developed. BK viral load peaked at ~800,000 copies/mL in 2015 with biopsy-proven BKVN, then resolved by 2018 after immunosuppression reduction. Ten years post-transplant, she developed graft dysfunction with creatinine 600 µmol/L and hydronephrosis. Initial imaging suggested clot retention, with transient improvement after nephrostomy. Recurrent dysfunction with BK viremia (~7,000 copies/mL) prompted repeat imaging which showed a vascularized 50×23×41 mm lesion.PET scan showed a hypermetabolic mass from lower pole to pelvi-ureteric junction without metastases. Urine cytology suggested high-grade UC and cystoscopy showed normal bladder .
Transplant nephroureterectomy done in May 2025,revealed high-grade papillary UC invading muscularis propria with staging pT3N0M0.
Tumor cells showed diffuse nuclear SV40 positivity (Figure 1); C4d was negative. Margins were clear. Immunosuppression was stopped, she was transitioned to hemodialysis.Recent Surveillance scans in March/2026 showed no recurrence.

Discussion

Although tumor BK DNA integration or large T-antigen mRNA testing was not performed, the allograft renal pelvis location, prior BKVN, recurrent viremia, and diffuse tumor-cell SV40 positivity support possible BKPyV-associated oncogenesis.
Take-away lesson: Recurrent or late BK viremia with clot-like obstruction,hydronephrosis and graft dysfunction should prompt evaluation for urothelial malignancy.

SV40 immunohistochemistry supporting BKPyV-associated tumor biology